>Judging from body language I would not think they are working on heparins for Teva…<
As a separate matter from the Teva/Procognia program on undisclosed compounds, I was musing about whether Procognia might have done some consulting for Teva on Teva’s Lovenox ANDA in order to strengthen the arguments vis-à-vis characterization. This would seem to be a non-trivial matter for MNTA investors. Regards, Dew
Market Data 
Markets 
AI
